Cargando…
The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma
BACKGROUND: The interval between the onset of Barrett's oesophagus (BO) and oesophageal adenocarcinoma (OAC) can be termed the incubation period. However, the unrecorded onset of BO precludes its direct observation. METHODS: Determining the range of intervals between BO diagnosis and OAC within...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142800/ https://www.ncbi.nlm.nih.gov/pubmed/21673678 http://dx.doi.org/10.1038/bjc.2011.214 |
_version_ | 1782208858300612608 |
---|---|
author | den Hoed, C M van Blankenstein, M Dees, J Kuipers, E J |
author_facet | den Hoed, C M van Blankenstein, M Dees, J Kuipers, E J |
author_sort | den Hoed, C M |
collection | PubMed |
description | BACKGROUND: The interval between the onset of Barrett's oesophagus (BO) and oesophageal adenocarcinoma (OAC) can be termed the incubation period. However, the unrecorded onset of BO precludes its direct observation. METHODS: Determining the range of intervals between BO diagnosis and OAC within the longest observational BO follow-up study. Exclusion criteria were presence of high-grade dysplasia (HGD) or OAC at baseline, death within <2 years of BO diagnosis, oesophagectomy without HGD/OAC and loss to follow-up. A total of 133 patients (M/F 73/60) were taken into account. RESULTS: In 1967 person years of follow-up there were 13 cases of HGD/OAC, (0.66% p.a.; 95% CI 0.58–0.74), 96 patients died without HGD/OAC and 24 survived without HGD/OAC. The mean intervals between BO diagnosis and either HGD/OAC, death or end of follow-up were 10.8, 12.6 and 25.5 years, respectively, and the mean ages at endpoint were 72.5, 80.0 and 68.3 years, respectively. The survivors without HGD/OAC had a lower age at BO diagnosis (mean 42.8 vs 61.2 and 67.4 years, P<0.001). Baseline presence of low-grade dysplasia was associated with progression to HGD/OAC (log rank P<0.001). CONCLUSION: The Rotterdam BO follow-up cohort revealed a long incubation period between onset of BO and development of HGD/OAC, in patients without HGD/OAC at baseline as illustrated by 24 patients diagnosed with BO at a young age and followed for a mean period of 25.5 years. Their tumour-free survival established a minimum incubation period, suggesting a true incubation period of three decades or more. |
format | Online Article Text |
id | pubmed-3142800 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-31428002012-07-12 The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma den Hoed, C M van Blankenstein, M Dees, J Kuipers, E J Br J Cancer Clinical Study BACKGROUND: The interval between the onset of Barrett's oesophagus (BO) and oesophageal adenocarcinoma (OAC) can be termed the incubation period. However, the unrecorded onset of BO precludes its direct observation. METHODS: Determining the range of intervals between BO diagnosis and OAC within the longest observational BO follow-up study. Exclusion criteria were presence of high-grade dysplasia (HGD) or OAC at baseline, death within <2 years of BO diagnosis, oesophagectomy without HGD/OAC and loss to follow-up. A total of 133 patients (M/F 73/60) were taken into account. RESULTS: In 1967 person years of follow-up there were 13 cases of HGD/OAC, (0.66% p.a.; 95% CI 0.58–0.74), 96 patients died without HGD/OAC and 24 survived without HGD/OAC. The mean intervals between BO diagnosis and either HGD/OAC, death or end of follow-up were 10.8, 12.6 and 25.5 years, respectively, and the mean ages at endpoint were 72.5, 80.0 and 68.3 years, respectively. The survivors without HGD/OAC had a lower age at BO diagnosis (mean 42.8 vs 61.2 and 67.4 years, P<0.001). Baseline presence of low-grade dysplasia was associated with progression to HGD/OAC (log rank P<0.001). CONCLUSION: The Rotterdam BO follow-up cohort revealed a long incubation period between onset of BO and development of HGD/OAC, in patients without HGD/OAC at baseline as illustrated by 24 patients diagnosed with BO at a young age and followed for a mean period of 25.5 years. Their tumour-free survival established a minimum incubation period, suggesting a true incubation period of three decades or more. Nature Publishing Group 2011-07-12 2011-06-14 /pmc/articles/PMC3142800/ /pubmed/21673678 http://dx.doi.org/10.1038/bjc.2011.214 Text en Copyright © 2011 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Study den Hoed, C M van Blankenstein, M Dees, J Kuipers, E J The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma |
title | The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma |
title_full | The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma |
title_fullStr | The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma |
title_full_unstemmed | The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma |
title_short | The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma |
title_sort | minimal incubation period from the onset of barrett's oesophagus to symptomatic adenocarcinoma |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142800/ https://www.ncbi.nlm.nih.gov/pubmed/21673678 http://dx.doi.org/10.1038/bjc.2011.214 |
work_keys_str_mv | AT denhoedcm theminimalincubationperiodfromtheonsetofbarrettsoesophagustosymptomaticadenocarcinoma AT vanblankensteinm theminimalincubationperiodfromtheonsetofbarrettsoesophagustosymptomaticadenocarcinoma AT deesj theminimalincubationperiodfromtheonsetofbarrettsoesophagustosymptomaticadenocarcinoma AT kuipersej theminimalincubationperiodfromtheonsetofbarrettsoesophagustosymptomaticadenocarcinoma AT denhoedcm minimalincubationperiodfromtheonsetofbarrettsoesophagustosymptomaticadenocarcinoma AT vanblankensteinm minimalincubationperiodfromtheonsetofbarrettsoesophagustosymptomaticadenocarcinoma AT deesj minimalincubationperiodfromtheonsetofbarrettsoesophagustosymptomaticadenocarcinoma AT kuipersej minimalincubationperiodfromtheonsetofbarrettsoesophagustosymptomaticadenocarcinoma |